Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Interest Expenses (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Interest Expenses for 2 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 8985.39% to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.7 million, a 3912.32% increase, with the full-year FY2025 number at $13.7 million, up 3912.32% from a year prior.
  • Interest Expenses was $8.1 million for Q4 2025 at Nuvation Bio, up from $5.1 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8.1 million in Q4 2025 to a low of $54000.0 in Q1 2025.